Computational Models for Designing Stem Cell Manufacturing Processes | iBB |

Current stem cell process design is guided by the envisioned demand and compliance with regulatory requirements. However, design of manufacturing processes streamlining for cost efficiency, while preparing a new therapy for approval and reimbursement, is often neglected. In an editorial of RegMedNet, a networking site that unites all members of the diverse regenerative medicine community, the use of computational models for designing stem cell manufacturing processes is discussed by SCERG-iBB researchers led by Joaquim Cabral in collaboration with Stan Finkelstein from MIT. Click on title to learn more.